Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Cian Healthcare Ltd Fundamentals

Market Cap
₹ 61.41 Cr
P/E Ratio (TTM)
245.70
P/B Ratio
1.06
Debt to Equity
1.10
ROE
1.77
EPS (TTM)
0.10
Dividend Yield
0.00 %
Book Value
23.10

Click here to know more about Fundamentals

Cian Healthcare Ltd Financials

Cian Healthcare Ltd Financials

Cian Healthcare Ltd Shareholding Pattern

Held By Mar 2024 Sep 2023 Mar 2023 Dec 2022
Retail 55.78 % 41.08 % 41.88 % 24.00 %
Promoters 27.10 % 49.62 % 51.85 % 66.26 %
Others 17.12 % 9.30 % 6.27 % 9.74 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %
FII 0.00 % 0.00 % 0.00 % 0.00 %

Retail

55.78%

Promoters

27.10%

Others

17.12%

Mutual Funds

0.00%

FII

0.00%

Retail

41.08%

Promoters

49.62%

Others

9.30%

Mutual Funds

0.00%

FII

0.00%

Retail

41.88%

Promoters

51.85%

Others

6.27%

Mutual Funds

0.00%

FII

0.00%

Retail

24.00%

Promoters

66.26%

Others

9.74%

Mutual Funds

0.00%

FII

0.00%

Resistance and Support

₹23.93

PIVOT

resistance-arrow
Resistance
First Resistance₹25.640
Second Resistance₹26.710
Third Resistance₹28.420
support-arrow
Support
First Support₹22.860
Second Support₹21.150
Third Support₹20.080

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day182,000114,00062.64
Week182,00081,6000.00
1 Month182,00066,9330.00
6 Months12,470,00010,936,00089.72

About Cian Healthcare Ltd

Cian Healthcare Limited was originally incorporated as a private limited company with the name of 'Cian Healthcare Private Limited' on January 07, 2003. Subsequently, the Company was converted into a public limited company pursuant to a special resolution passed by the shareholders dated November 19, 2018 and the name of the Company was changed to 'Cian Healthcare Limited' to reflect the legal status of the Company pursuant to a fresh certificate of incorporation granted by the Registrar of Companies, Pune dated November 30, 2018. The Company is a WHO-GMP & ISO-9001:2015 certified transnational manufacturing Company with wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products. The Company has a full-fledged F & D and regulatory department. The Company complies with the standard manufacturing practices as laid down by the World Health Organization and is also certified by the Food and Drug Control Administration The Company develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, alongwith 10 sales division focused on developing and growing its engagements in specialist and super specialist division. The company works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies. The Company has product approvals under the license issued by Drug Controlling & Licensing Authority Uttarkhand, under the license no. 82/UA/2006 in Form of 25 and 82/UA/SC/P-2006 Form of 28 for manufacturing of Tablets, Capsules, Oral Liquids and Ointments and also for analysis of Chemical, Instrumental & Microbiology. The Company manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet. The Company has special licence for manufacturing veterinary products for client like SAVAvet and Venky's. Cian has developed more than 1,000 formulations and 2000 brands for domestic market under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals. The Company is managed by a team of professionals headed by its Managing Director, having experience in the field of manufacturing of Pharmaceuticals products. The manufacturing process is supported by Total Quality Management techniques (TQM) and is supervised through various quality control equipments and qualified personnel. The Products are manufactured for domestic and foreign markets. The Company entered the International market in the year 2013-14 and are on regular basis exporting its products to various countries.

Managing Director

Suraj Zanwar

Founded

2003

NSE Symbol

NA

Cian Healthcare Ltd Management

NameDesignation
Suraj ZanwarManaging Director
Munjaji Purbhaji DhumalCompany Sec. & Compli. Officer
Swati MaheshwariIndependent Director
Paresh Arun ShahDirector
Sunil KumarIndependent Director

Events

Board Meeting Announcement for Cian Healthcare Ltd - Jun 14, 2024

Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2024 inter alia to consider and approve To D...

Read More

Board Meeting Announcement for Cian Healthcare Ltd - Jun 14, 2024

Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2024 inter alia to consider and approve To D...

Read More

Board Meeting Announcement for Cian Healthcare Ltd - Jun 14, 2024

Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2024 inter alia to consider and approve To D...

Read More

Cian Healthcare Ltd News

Cian Healthcare schedules board meeting
On 14 June 2024
Cian Healthcare to conduct board meeting
On 5 June 2024
Cian Healthcare to hold board meeting
On 30 May 2024
Cian Healthcare to convene board meeting
On 14 November 2023
Cian Healthcare AGM scheduled
On 30 September 2023
Cian Healthcare to convene board meeting
On 30 May 2023
Cian Healthcare to conduct EGM
On 13 May 2023
Cian Healthcare to hold board meeting
On 14 November 2022
Cian Healthcare to hold board meeting
On 26 September 2022
Cian Healthcare AGM scheduled
On 30 September 2022

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
Sun Pharmaceuticals Industries Ltd₹ 363691.19 Cr
₹ 1,515.80
(0.39 %)
119.64
Cipla Ltd₹ 126389.48 Cr
₹ 1,565.30
(1.42 %)
34.03
Divis Laboratories Ltd₹ 121763.8 Cr
₹ 4,586.75
(-0.14 %)
77.26
Zydus Lifesciences Ltd₹ 111571.22 Cr
₹ 1,108.80
(1.70 %)
32.35
Dr Reddys Laboratories Ltd₹ 101503.45 Cr
₹ 6,084.45
(-0.17 %)
23.38

Cian Healthcare Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Cian Healthcare Ltd shares in BlinkX

Cian Healthcare Ltd's P/E ratio is 245.70 times as of June 14, 2024 at 04:00 PM.

Cian Healthcare Ltd's most recent financial reports indicate a price-to-book ratio of 1.06, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Cian Healthcare Ltd's market is 61 Cr as on June 14, 2024 at 04:00 PM.

The current financial records of Cian Healthcare Ltd show a 1.77% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

According to Cian Healthcare Ltd's most recent financial filings, the company has a total asset value of Crores, which includes current and non-current assets such as inventory, cash, properties, and equipment.

As of the Mar 2024 quarter, the promoter shareholding in Cian Healthcare Ltd stands at 27.10%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.